课题基金 / 基金详情

项目摘要

项目成果

TRACY A GLAUSER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): CinciNEXT is a unique collaboration between the free-standing Cincinnati Children's Hospital Medical Center (CCHMC) and the University of Cincinnati (UC) that aims to be a clinical site in the NlNDS-funded Network for Excellence in Neuroscience Clinical Trials (NEXT) network. The objective of the proposed application is to obtain infrastructural support to facilitate the implementation and optimize the quality of clinica trials conducted at the CinciNEXT site for the NEXT Network. Specific goals of CinciNEXT are to streamline startup, enhance recruitment, maximize retention and optimize study conduct of NEXT Network studies. Another goal is to actively contribute to the overall success of the NEXT network by participating in network governance, working groups (e.g. focused on planning and implementation of protocols), and network activities. The third goal is to implement ongoing training of new/junior clinical investigators/study coordinators to help them develop skills and experience to participate and/or lead future NEXT and other NINDS trials. These goals will be achieved by the combination of our experienced CinciNEXT leadership team (two co-Pls and two full-time research study coordinators), enthusiastic research collaborators, existing outstanding research infrastructure (including a CTSA), robust breadth and depth of patients available to participate in trials, and two supportive research administrations. Both institutions have shown their commitment to the NEXT Network by agreeing to use a standardized Master Trial Agreement, employ a Tier 1 level of centralized IRB review, and provide additional institutional funds to support two full-time CinciNEXT study coordinators (one pediatric-focused and one adult-focused). The CinciNEXT clinical site anticipates providing outstanding recruitment, retention and quality for NEXT Network trials, and thereby advancing treatments for neurological disorders. CinciNEXT proposes to be a key partner in this NINDS network that will provide a robust, standardized, and accessible infrastructure to facilitate rapid development and implementation of protocols in neurological disorders affecting adult and pediatric populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Pharmacology K12 Training Program
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
  • 批准号:
    10166966
  • 项目类别:
  • 资助金额:
    $30.45万
  • 财政年份:
    2018
  • 负责人:
    TRACY A GLAUSER
  • 依托单位:
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)
  • 批准号:
    10744306
  • 项目类别:
  • 资助金额:
    $46.02万
  • 财政年份:
    2018
  • 负责人:
    TRACY A GLAUSER
  • 依托单位:
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)
  • 批准号:
    10593621
  • 项目类别:
  • 资助金额:
    $29.95万
  • 财政年份:
    2018
  • 负责人:
    TRACY A GLAUSER
  • 依托单位:
海外基金